Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 661

1.

HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms.

Alessandria C, Caviglia GP, Campion D, Nalbone F, Sanna C, Musso A, Abate ML, Rizzetto M, Saracco GM, Balzola F.

J Pediatr Gastroenterol Nutr. 2019 Jul;69(1):39-44. doi: 10.1097/MPG.0000000000002293.

PMID:
31232884
2.

Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study.

Rosso C, Caviglia GP, Ciruolo M, Ciancio A, Younes R, Olivero A, Giordanino C, Troshina G, Abate ML, Rizzetto M, Pellicano R, Saracco GM, Bugianesi E, Smedile A.

Minerva Med. 2019 May 6. doi: 10.23736/S0026-4806.19.06108-1. [Epub ahead of print]

PMID:
31081312
3.

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy.

Yurdaydin C, Abbas Z, Buti M, Cornberg M, Esteban R, Etzion O, Gane EJ, Gish RG, Glenn JS, Hamid S, Heller T, Koh C, Lampertico P, Lurie Y, Manns M, Parana R, Rizzetto M, Urban S, Wedemeyer H; Hepatitis Delta International Network (HDIN).

J Hepatol. 2019 May;70(5):1008-1015. doi: 10.1016/j.jhep.2018.12.022. Epub 2018 Dec 27. Review.

PMID:
30982526
4.

Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II).

Asselah T, Alami NN, Moreno C, Pol S, Karatapanis S, Gschwantler M, Horsmans Y, Elefsiniotis I, Larrey D, Ferrari C, Rizzetto M, Orlandini A, Calleja JL, Bruno S, Schnell G, Qaqish R, Redman R, Pilot-Matias T, Kopecky-Bromberg S, Yu Y, Mobashery N.

Health Sci Rep. 2019 Mar 1;2(3):e92. doi: 10.1002/hsr2.92. eCollection 2019 Mar.

5.

HLA-DQ Genotyping, Duodenal Histology, and Response to Exclusion Diet in Autistic Children With Gastrointestinal Symptoms.

Alessandria C, Caviglia GP, Campion D, Nalbone F, Sanna C, Musso A, Abate ML, Rizzetto M, Saracco GM, Balzola F.

J Pediatr Gastroenterol Nutr. 2019 Feb 7. doi: 10.1097/MPG.0000000000002293. [Epub ahead of print]

PMID:
30747811
6.

Quantitation of anti-HBe antibodies in anti-HBc-positive liver donors.

Caviglia GP, Tandoi F, Olivero A, Saracco GM, Rizzetto M, Romagnoli R, Smedile A.

J Hepatol. 2019 Apr;70(4):793-795. doi: 10.1016/j.jhep.2018.11.023. Epub 2018 Dec 24. No abstract available.

PMID:
30591262
7.

Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D.

Lampertico P, Brunetto MR, Craxì A, Gaeta GB, Rizzetto M, Rozzi A, Colombo M; HERMES Study Group.

J Viral Hepat. 2019 Jan;26(1):118-125. doi: 10.1111/jvh.12999. Epub 2018 Dec 11.

PMID:
30187599
8.

Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.

Karimzadeh H, Kiraithe MM, Kosinska AD, Glaser M, Fiedler M, Oberhardt V, Salimi Alizei E, Hofmann M, Mok JY, Nguyen M, van Esch WJE, Budeus B, Grabowski J, Homs M, Olivero A, Keyvani H, Rodríguez-Frías F, Tabernero D, Buti M, Heinold A, Alavian SM, Bauer T, Schulze Zur Wiesch J, Raziorrouh B, Hoffmann D, Smedile A, Rizzetto M, Wedemeyer H, Timm J, Antes I, Neumann-Haefelin C, Protzer U, Roggendorf M.

J Virol. 2018 Jun 13;92(13). pii: e01891-17. doi: 10.1128/JVI.01891-17. Print 2018 Jul 1.

9.

Quantitation of HBV cccDNA in anti-HBc-positive liver donors by droplet digital PCR: A new tool to detect occult infection.

Caviglia GP, Abate ML, Tandoi F, Ciancio A, Amoroso A, Salizzoni M, Saracco GM, Rizzetto M, Romagnoli R, Smedile A.

J Hepatol. 2018 Aug;69(2):301-307. doi: 10.1016/j.jhep.2018.03.021. Epub 2018 Apr 3.

10.

Declining prevalence and increasing awareness of HCV infection in Italy: A population-based survey in five metropolitan areas.

Andriulli A, Stroffolini T, Mariano A, Valvano MR, Grattagliano I, Ippolito AM, Grossi A, Brancaccio G, Coco C, Russello M, Smedile A, Petrini E, Martini S, Gaeta GB, Rizzetto M.

Eur J Intern Med. 2018 Jul;53:79-84. doi: 10.1016/j.ejim.2018.02.015. Epub 2018 Feb 21.

PMID:
29475770
11.

Targeting Hepatitis D.

Rizzetto M.

Semin Liver Dis. 2018 Feb;38(1):66-72. doi: 10.1055/s-0037-1621711. Epub 2018 Feb 22. Review.

PMID:
29471567
12.

Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D?

Martini S, Caccamo L, Rizzetto M.

Hepatology. 2018 Jun;67(6):2475-2476. doi: 10.1002/hep.29796. Epub 2018 Apr 25. No abstract available.

PMID:
29356031
13.

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).

Wranke A, Pinheiro Borzacov LM, Parana R, Lobato C, Hamid S, Ceausu E, Dalekos GN, Rizzetto M, Turcanu A, Niro GA, Lubna F, Abbas M, Ingiliz P, Buti M, Ferenci P, Vanwolleghem T, Hayden T, Dashdorj N, Motoc A, Cornberg M, Abbas Z, Yurdaydin C, Manns MP, Wedemeyer H, Hardtke S; Hepatitis Delta International Network.

Liver Int. 2018 May;38(5):842-850. doi: 10.1111/liv.13604. Epub 2017 Oct 26.

PMID:
28963781
14.

Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents.

Ciancio A, Bosio R, Bo S, Pellegrini M, Sacco M, Vogliotti E, Fassio G, Bianco Mauthe Degerfeld AGF, Gallo M, Giordanino C, Terzi di Bergamo L, Ribaldone D, Bugianesi E, Smedile A, Rizzetto M, Saracco GM.

J Med Virol. 2018 Feb;90(2):320-327. doi: 10.1002/jmv.24954. Epub 2017 Nov 14.

PMID:
28960353
15.

Investigational drugs in development for Hepatitis D.

Rizzetto M.

Expert Opin Investig Drugs. 2017 Sep;26(9):999-1005. doi: 10.1080/13543784.2017.1357695. Epub 2017 Jul 28. Review.

PMID:
28730878
16.

Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.

Caviglia GP, Abate ML, Gaia S, Petrini E, Bosco C, Olivero A, Rosso C, Ciancio A, Pellicano R, Saracco GM, Rizzetto M, Smedile A.

Panminerva Med. 2017 Dec;59(4):283-289. doi: 10.23736/S0031-0808.17.03353-5. Epub 2017 Jun 23.

PMID:
28650134
17.

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.

Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS Jr, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, Müllhaupt B.

Ann Hepatol. 2017 May - Jun;16(3):375-381. doi: 10.5604/16652681.1235480.

18.

Letter: HBsAg kinetics-guided interferon therapy for chronic hepatitis D - authors' reply.

Niro GA, Smedile A, Andriulli A, Rizzetto M.

Aliment Pharmacol Ther. 2017 Feb;45(3):481-482. doi: 10.1111/apt.13892. No abstract available.

19.

Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant.

Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS Jr, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, Müllhaupt B.

Ann Hepatol. 2017 May - Jun;16(3):375-381. doi: 10.5604/01.3001.0009.8592.

20.

Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.

Kim YA, Estevez J, Le A, Israelski D, Baatarkhuu O, Sarantuya T, Narantsetseg S, Nymadawa P, H Le R, Yuen MF, Dusheiko G, Rizzetto M, Nguyen MH.

BMJ Open Gastroenterol. 2016 Nov 10;3(1):e000119. eCollection 2016.

21.

Etiology of chronic liver diseases in the Northwest of Italy, 1998 through 2014.

Saracco GM, Evangelista A, Fagoonee S, Ciccone G, Bugianesi E, Caviglia GP, Abate ML, Rizzetto M, Pellicano R, Smedile A.

World J Gastroenterol. 2016 Sep 28;22(36):8187-93. doi: 10.3748/wjg.v22.i36.8187.

22.

Hepatitis B core-related antigen kinetics in chronic hepatitis B virus genotype D-infected patients treated with nucleos(t)ide analogues or pegylated-interferon-α.

Caviglia GP, Abate ML, Noviello D, Olivero A, Rosso C, Troshina G, Ciancio A, Rizzetto M, Saracco GM, Smedile A.

Hepatol Res. 2017 Jul;47(8):747-754. doi: 10.1111/hepr.12811. Epub 2016 Sep 27.

23.

[Chronic hepatitis B: standard of therapy and perspectives].

Rizzetto M.

Recenti Prog Med. 2016 Jul;107(7):355-9. doi: 10.1701/2318.24926. Italian.

PMID:
27571465
24.

Myrcludex B, a novel therapy for chronic hepatitis D?

Rizzetto M, Niro GA.

J Hepatol. 2016 Sep;65(3):465-6. doi: 10.1016/j.jhep.2016.06.014. No abstract available.

PMID:
27538763
25.

HBsAg kinetics in chronic hepatitis D during interferon therapy: on-treatment prediction of response.

Niro GA, Smedile A, Fontana R, Olivero A, Ciancio A, Valvano MR, Pittaluga F, Coppola N, Wedemeyer H, Zachou K, Marrone A, Fasano M, Lotti G, Andreone P, Iacobellis A, Andriulli A, Rizzetto M.

Aliment Pharmacol Ther. 2016 Sep;44(6):620-8. doi: 10.1111/apt.13734. Epub 2016 Jul 22.

26.

Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis.

Martini S, Sacco M, Strona S, Arese D, Tandoi F, Dell Olio D, Stradella D, Cocchis D, Mirabella S, Rizza G, Magistroni P, Moschini P, Ottobrelli A, Amoroso A, Rizzetto M, Salizzoni M, Saracco GM, Romagnoli R.

Liver Int. 2017 Jan;37(1):62-70. doi: 10.1111/liv.13193. Epub 2016 Jul 20.

27.

Early reduced liver graft survival in hepatitis C recipients identified by two combined genetic markers.

Romagnoli R, Martini S, Tandoi F, Dell Olio D, Magistroni P, Bertinetto FE, Dametto E, Rizzetto M, Salizzoni M, Amoroso A.

Transpl Int. 2016 Oct;29(10):1070-84. doi: 10.1111/tri.12795. Epub 2016 Jun 4.

28.

Chronic Hepatitis D; at a Standstill?

Rizzetto M.

Dig Dis. 2016;34(4):303-7. doi: 10.1159/000444467. Epub 2016 May 11. Review.

PMID:
27170382
29.

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.

Manns M, Samuel D, Gane EJ, Mutimer D, McCaughan G, Buti M, Prieto M, Calleja JL, Peck-Radosavljevic M, Müllhaupt B, Agarwal K, Angus P, Yoshida EM, Colombo M, Rizzetto M, Dvory-Sobol H, Denning J, Arterburn S, Pang PS, Brainard D, McHutchison JG, Dufour JF, Van Vlierberghe H, van Hoek B, Forns X; SOLAR-2 investigators.

Lancet Infect Dis. 2016 Jun;16(6):685-697. doi: 10.1016/S1473-3099(16)00052-9. Epub 2016 Feb 18. Erratum in: Lancet Infect Dis. 2016 Jun;16(6):636.

PMID:
26907736
30.

The adventure of delta.

Rizzetto M.

Liver Int. 2016 Jan;36 Suppl 1:135-40. doi: 10.1111/liv.13018. Review.

PMID:
26725911
31.

Cytokeratin 18-Aspartate396 apoptotic fragment for fibrosis detection in patients with non-alcoholic fatty liver disease and chronic viral hepatitis.

Rosso C, Caviglia GP, Abate ML, Vanni E, Mezzabotta L, Touscoz GA, Olivero A, Marengo A, Rizzetto M, Bugianesi E, Smedile A.

Dig Liver Dis. 2016 Jan;48(1):55-61. doi: 10.1016/j.dld.2015.09.008. Epub 2015 Sep 28.

PMID:
26514735
32.

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.

Rosso C, Mezzabotta L, Gaggini M, Salomone F, Gambino R, Marengo A, Saba F, Vanni E, Younes R, Saponaro C, Buzzigoli E, Caviglia GP, Abate ML, Smedile A, Rizzetto M, Cassader M, Gastaldelli A, Bugianesi E.

Hepatology. 2016 Jan;63(1):107-16. doi: 10.1002/hep.28287. Epub 2015 Dec 8. Erratum in: Hepatology. 2017 Sep;66(3):1011.

PMID:
26473614
33.

Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4).

Hézode C, Alric L, Brown A, Hassanein T, Rizzetto M, Buti M, Bourlière M, Thabut D, Molina E, Rustgi V, Samuel D, McPhee F, Liu Z, Yin PD, Hughes E, Treitel M; COMMAND-4 study team.

Antivir Ther. 2015 Aug 27;21(3):195-205. doi: 10.3851/IMP2985. [Epub ahead of print]

PMID:
26313445
34.

Usefulness of thromboelastometry in predicting the risk of bleeding in cirrhotics who undergo invasive procedures.

Debernardi Venon W, Ponzo P, Sacco M, Mengozzi G, Raso S, Valpreda A, Rizzetto M, Marzano A.

Eur J Gastroenterol Hepatol. 2015 Nov;27(11):1313-9. doi: 10.1097/MEG.0000000000000442.

PMID:
26225869
35.

Endoscopic ultrasound in common bile duct dilatation with normal liver enzymes.

De Angelis C, Marietti M, Bruno M, Pellicano R, Rizzetto M.

World J Gastrointest Endosc. 2015 Jul 10;7(8):799-805. doi: 10.4253/wjge.v7.i8.799. Review.

36.

The prenylation inhibitor, lonafarnib: a new therapeutic strategy against hepatitis delta.

Rizzetto M, Ciancio A.

Lancet Infect Dis. 2015 Oct;15(10):1119-1120. doi: 10.1016/S1473-3099(15)00155-3. Epub 2015 Jul 16. No abstract available.

37.

Hepatorenal syndrome after treatment of visceral leishmaniasis requiring terlipressin therapy.

Marzano A, Debernardi Venon W, Sacco M, Rizzetto M.

Minerva Gastroenterol Dietol. 2015 Sep;61(3):171-2. No abstract available.

PMID:
26161570
38.

Hepatitis D Virus: Introduction and Epidemiology.

Rizzetto M.

Cold Spring Harb Perspect Med. 2015 Jul 1;5(7):a021576. doi: 10.1101/cshperspect.a021576. Review.

39.

Highly sensitive alpha-fetoprotein, Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxyprothrombin for hepatocellular carcinoma detection.

Caviglia GP, Abate ML, Petrini E, Gaia S, Rizzetto M, Smedile A.

Hepatol Res. 2016 Mar;46(3):E130-5. doi: 10.1111/hepr.12544. Epub 2015 Jul 6.

40.

Adrenal function and microbial DNA in noninfected cirrhotic patients with ascites: Relationship and effect on survival.

Risso A, Alessandria C, Mezzabotta L, Elia C, Andrealli A, Spandre M, Di Luigi P, Barbui A, Evangelista A, Morgando A, Serra R, Ciccone G, Marzano A, Rizzetto M.

Dig Liver Dis. 2015 Aug;47(8):702-8. doi: 10.1016/j.dld.2015.04.010. Epub 2015 Apr 24.

PMID:
25990615
41.

Helicobacter pylori in celiac disease and in duodenal intraepithelial lymphocytosis: Active protagonist or innocent bystander?

Simondi D, Ribaldone DG, Bonagura GA, Foi S, Sapone N, Garavagno M, Villanacci V, Bernardi D, Pellicano R, Rizzetto M, Astegiano M.

Clin Res Hepatol Gastroenterol. 2015 Dec;39(6):740-5. doi: 10.1016/j.clinre.2015.03.005. Epub 2015 May 5.

PMID:
25956489
42.

PEX7 Mutations Cause Congenital Cataract Retinopathy and Late-Onset Ataxia and Cognitive Impairment: Report of Two Siblings and Review of the Literature.

Nanetti L, Pensato V, Leoni V, Rizzetto M, Caccia C, Taroni F, Mariotti C, Gellera C.

J Clin Neurol. 2015 Apr;11(2):197-9. doi: 10.3988/jcn.2015.11.2.197. No abstract available.

43.

Antiviral treatment discontinuation among hepatitis C-infected individuals with thrombocytopenia.

Irving WL, Grotzinger K, Theodore D, Demuth D, Rizzetto M, Roughley A, Forssen U.

J Viral Hepat. 2015 May;22(5):511. doi: 10.1111/jvh.12357. No abstract available.

PMID:
25847467
44.

Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study.

Coppo C, Bonfanti D, Bo S, Giordanino C, Gallo M, Cococcia S, Ciccone G, Smedile A, Ciancio A, Bugianesi E, Fagoonee S, Pellicano R, Rizzetto M, Saracco GM.

Dig Liver Dis. 2015 May;47(5):405-10. doi: 10.1016/j.dld.2015.01.157. Epub 2015 Feb 7.

45.

ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy.

Cusato J, Allegra S, De Nicolò A, Boglione L, Fatiguso G, Cariti G, Ciancio A, Smedile A, Strona S, Troshina G, Rizzetto M, Di Perri G, D'Avolio A.

Biomed Pharmacother. 2015 Feb;69:63-9. doi: 10.1016/j.biopha.2014.11.007. Epub 2014 Nov 15.

PMID:
25661339
46.

Non-invasive score system for fibrosis in chronic hepatitis: proposal for a model based on biochemical, FibroScan and ultrasound data.

Gaia S, Campion D, Evangelista A, Spandre M, Cosso L, Brunello F, Ciccone G, Bugianesi E, Rizzetto M.

Liver Int. 2015 Aug;35(8):2027-35. doi: 10.1111/liv.12761. Epub 2015 Jan 21.

47.

Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.

Bernabucci V, Ciancio A, Petta S, Karampatou A, Turco L, Strona S, Critelli R, Todesca P, Cerami C, Sagnelli C, Rizzetto M, Cammà C, Villa E.

World J Gastroenterol. 2014 Nov 28;20(44):16726-33. doi: 10.3748/wjg.v20.i44.16726.

48.

Antiplatelet and anticoagulant drugs management before gastrointestinal endoscopy: do clinicians adhere to current guidelines?

Bruno M, Marengo A, Elia C, Caronna S, Debernardi-Venon W, Manfrè SF, Musso A, Puglisi F, Sguazzini C, Rizzetto M, De Angelis C.

Dig Liver Dis. 2015 Jan;47(1):45-9. doi: 10.1016/j.dld.2014.10.017. Epub 2014 Nov 1.

PMID:
25464898
49.

Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.

Bonomi A, Lisini D, Navone SE, Frigerio S, Dossena M, Ciusani E, Rampini P, Marfia G, Coccè V, Cavicchini L, Sisto F, Parati E, Mantegazza R, Rimoldi M, Rizzetto M, Alessandri G, Pessina A.

Cytotherapy. 2015 Mar;17(3):310-9. doi: 10.1016/j.jcyt.2014.09.009. Epub 2014 Oct 28.

PMID:
25457277
50.

Chronic hepatitis C virus infection and lymphoproliferative disorders: mixed cryoglobulinemia syndrome, monoclonal gammopathy of undetermined significance, and B-cell non-Hodgkin lymphoma.

Caviglia GP, Sciacca C, Abate ML, Olivero A, Rosso C, Touscoz GA, Ciancio A, Rizzetto M, Smedile A.

J Gastroenterol Hepatol. 2015 Apr;30(4):742-7. doi: 10.1111/jgh.12837.

Supplemental Content

Loading ...
Support Center